Summary & Overview
HCPCS J2598: Vasopressin Injection, 1 Unit
HCPCS Level II code J2598 denotes the injectable medication vasopressin, billed per 1 unit. Vasopressin is a vasoactive agent used in acute care settings for hemodynamic support, often in critical care and emergency medicine. Nationally, accurate reporting of drug J-codes like J2598 affects claims processing, pharmacy billing workflows, and aggregate medication utilization metrics across payers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for vasopressin use, common sites of service where this code is applied, and typical billing considerations tied to HCPCS J-code reporting. The publication summarizes payer coverage patterns, where available, and standard administrative practices for documenting parenteral vasoactive therapy.
The piece also outlines what readers can expect: benchmark benchmarks and utilization indicators where available, descriptions of coding and billing workflows, and notes on documentation elements relevant to payers and providers. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J2598 represents an injection of vasopressin, dosed as 1 unit per billing unit. This code is used to report administration of vasopressin as a medication.
Service type: Medication administration / injectable drug therapy
Typical site of service: Inpatient hospital settings, emergency department, or other acute care settings where parenteral vasoactive medications are administered
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient in the intensive care unit develops vasodilatory shock after major abdominal surgery with persistent hypotension despite adequate fluid resuscitation and titrated catecholamine vasopressors. The attending critical care physician orders a vasopressin injection to support mean arterial pressure and reduce catecholamine requirements. Pharmacy prepares J2598 (injection, vasopressin, 1 unit) for either intravenous bolus or continuous infusion after dilution per institutional protocol. Administration typically occurs in an inpatient acute care setting (ICU or step-down unit) under physician or advanced practice provider order, with monitoring of hemodynamics, urine output, and serum electrolytes. Documentation includes indication (e.g., vasodilatory septic shock), dose administered in units, route, time, response, and any relevant modifier usage reflecting billing circumstances.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier used (placeholder) | Rarely used; not typically appended to HCPCS codes for professional billing. |
22 | Increased procedural services |